Skip to content
Twitter Linkedin
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
      • Filing in the US
      • Regulatory Affairs | UK and Europe
      • CMC Regulatory Affairs
      • Medical Devices
      • SME Status via Boyds
    • Clinical and Medical Affairs
      • Interim Chief Medical Officer
      • Medical Monitoring
      • Scientific and Medical Advice
      • Support for Medical Directors and Chief Medical Officers
      • Meet the Medics
    • Clinical Operations
      • Biostatistics
      • Clinical Project Management
      • Clinical Site Monitoring
      • Clinical Study Start-Up
    • Pharmaceutical Due Diligence
    • Product Development
      • Investor Readiness
    • Regulatory Operations and Publishing
      • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Early Access Programs and Real-World Data Collection
    • My Development TEAM
  • Latest
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast | Conversations in Drug Development
  • Regulatory Updates
  • Resources
    • Factsheets
    • Publications
    • Webinars
  • Contact us
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
      • Filing in the US
      • Regulatory Affairs | UK and Europe
      • CMC Regulatory Affairs
      • Medical Devices
      • SME Status via Boyds
    • Clinical and Medical Affairs
      • Interim Chief Medical Officer
      • Medical Monitoring
      • Scientific and Medical Advice
      • Support for Medical Directors and Chief Medical Officers
      • Meet the Medics
    • Clinical Operations
      • Biostatistics
      • Clinical Project Management
      • Clinical Site Monitoring
      • Clinical Study Start-Up
    • Pharmaceutical Due Diligence
    • Product Development
      • Investor Readiness
    • Regulatory Operations and Publishing
      • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Early Access Programs and Real-World Data Collection
    • My Development TEAM
  • Latest
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast | Conversations in Drug Development
  • Regulatory Updates
  • Resources
    • Factsheets
    • Publications
    • Webinars
  • Contact us
Linkedin X-twitter Spotify Youtube
  • Home
  • About

    About Boyds

    A global drug development consultancy supporting cutting-edge development.

    Find out more
    • Why Boyds
    • Our Team
    • Vision and Values
    • Why Boyds
    • Our Team
    • Vision and Values
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
    • Boyds’ ESG Commitments
    • Working at Boyds
    • Join Us
  • Services
    • Regulatory Affairs
    • Filing in the US
    • Filing in the UK & Europe
    • CMC Regulatory Affairs
    • Medical Devices
    • SME Status via Boyds
    • Filing in the US
    • Filing in the UK & Europe
    • CMC Regulatory Affairs
    • Medical Devices
    • SME Status via Boyds
    • Regulatory Operations and Submissions Support
    • Regulatory Submission Pathways
    • Regulatory Submission Pathways
    • Regulatory and Medical Writing
    • Clinical and Medical Affairs
    • Interim Medical Support
    • Medical Monitoring
    • Scientific and Medical Advice
    • Support for Medical Directors and Chief Medical Officers
    • Meet the Medics
    • Interim Medical Support
    • Medical Monitoring
    • Scientific and Medical Advice
    • Support for Medical Directors and Chief Medical Officers
    • Meet the Medics
    • Clinical Operations
    • Biostatistics
    • Clinical Project Management
    • Clinical Site Monitoring
    • Clinical Study Start-Up Support
    • Biostatistics
    • Clinical Project Management
    • Clinical Site Monitoring
    • Clinical Study Start-Up Support
    • Product Development
    • Investor Readiness
    • Investor Readiness
    • Pharmaceutical Due Diligence
    • Early Access Programs and Real-World Data Collection
    Why Boyds?

    Integrated drug development expertise, from concept to patient.

    • Explore our approach
  • Latest
    Conversations in Drug Development

    Latest Podcast

    Listen to the latest podcast episode of Conversation in Drug Development

    • News
    • Blogs
    • Case Studies
    • News
    • Blogs
    • Case Studies
    • Events
    • Podcast
    • Events
    • Podcast
  • Regulatory Updates
  • Resources

    Regulatory Updates

    Subscribe to the Regulatory Intelligence Digest to receive the latest guidance in medicines regulations

    Subscribe
    • Resources
    • Factsheets
    • Resources
    • Factsheets
    • Publications
    • Webinars
    • Publications
    • Webinars
Contact Us

Case Studies

study start-up support
Case Studies

Strategic study start-up support in the UK and Europe

Read More »
July 25, 2023
Gene therapy expertise
Case Studies

Combined gene therapy expertise supports US biotech

Read More »
May 18, 2023
Case Studies

Expansion of oncology clinical programme into other indications

Read More »
April 6, 2023
Case Studies

Supporting new biotech companies spinning out of academia

Read More »
April 3, 2023
Case Studies

Product development support to benchmark novel medical food product

Read More »
March 28, 2023
Case Studies

Boyds supports acquisition of UK-based oncology drug developer with scientific due diligence

Read More »
November 21, 2022
« Previous Page1 Page2 Page3 Next »

Speak to a member of the team today

Contact Us

Contact Us

UK +44 (0)1270 270010
US +1 800 982 7431
E info@boydconsultants.com

Twitter Linkedin Youtube Spotify Apple

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical and Medical Affairs
  • Pharma Due Diligence
  • Regulatory Operations

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

Boyds is the trading name of Boyds International Life Sciences Group Limited registered in England and Wales. Registered Number: 13521126 © Boyds 2026. All Rights Reserved.

Privacy Policy      Contact

arrow